Kristy Ainslie/pharmacy.unc.edu
Mar 6, 2026, 15:43
Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
Kristy Ainslie, Fred Eshelman Distinguished Professor and Director at University of North Carolina at Chapel Hill, shared a post on LinkedIn:
“Ever wonder about the discovery and FDA approval of your favorite drug carrier? I’ve broken them down and highlighted each advancement – with references!
Enjoy and let me know if think I forgot something.
Part 1 – Living Medicine
Part 2 – Complex Biologics
Part 3 – Inorganic Carriers
Part 4 – Other Carriers
Part 5 – Nucleic Acids and Lipids
Part 6 – Polymers
Part 7 – Proteins
Part 8 – Devices”
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 16:16Christopher Pittman: Superficial Venous Disease Needs Arterial-Level Follow-Up
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL
-
Apr 22, 2026, 15:28ASH Committee Brings the Voice of Hematology to Capitol Hill
-
Apr 22, 2026, 15:22Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
-
Apr 22, 2026, 14:51Mavis Agnes Kisakye: Reconnecting to Drive the Global Bleeding Disorders Agenda Forward
-
Apr 22, 2026, 14:48Augustina Isioma Ikusemoro: Not Every Antigen Speaks Loudly, But the Right Test Will Hear It
-
Apr 22, 2026, 14:47Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
-
Apr 22, 2026, 14:46David Brown: Charting a New Path Forward for One Patient Facing Extraordinary Cardiac Challenges
-
Apr 22, 2026, 14:45Ney Carter Borges: Syphilis and Cardiovascular Risk – A Silent and Progressive Vascular Burden